More recently, GLP-1 RA drugs have been approved for weight loss, cardiovascular disease, and chronic kidney disease
Its approved to treat adults and pediatric patients 12 years and older with obesity who weigh more than 60 kg (132 pounds)
The ophthalmic system, in many ways, serves as an extension of the brain
In one 2024 real-world study, 40% of GLP-1 patients had inadequate protein intake, and 25% had suboptimal vitamin D, B12, iron, or calcium within 3 months of starting therapy
By combining muscle-building EMSculpt Neo technology, advanced Ultraformer HIFU treatments, precision biostimulators, targeted laser therapies, and supportive IV treatments, we create a customised solution that addresses all aspects of body transformation during medication-assisted weight loss
Cheng J, Palva AM, de Vos WM, Satokari R